Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model
Elisa Landucci, Costanza Mazzantini, Daniele Lana, et al.
Neurobiology of Disease (2022) Vol. 174, pp. 105895-105895
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Cannabidiol prevents LPS-induced inflammation by inhibiting the NLRP3 inflammasome and iNOS activity in BV2 microglia cells via CB2 receptors and PPARγ
Fernanda da Silva Rodrigues, William Robert Newton, Isadora D’Ávila Tassinari, et al.
Neurochemistry International (2024) Vol. 177, pp. 105769-105769
Open Access | Times Cited: 11
Development and Blood–Brain Barrier Penetration of Nanovesicles Loaded with Cannabidiol
Lucia Grifoni, Elisa Landucci, Giuseppe Pieraccini, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 160-160
Open Access | Times Cited: 1
Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance
Stefano De Martini, Alessandra Gemma, Marco Ferrari, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3125-3125
Open Access | Times Cited: 16
Cannabinoids and endocannabinoids as therapeutics for nervous system disorders: preclinical models and clinical studies
R. Scott Duncan, Sean M. Riordan, Matthew C. Gernon, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 4, pp. 788-799
Open Access | Times Cited: 14
A case for seeking sex-specific treatments in Alzheimer’s disease
Marina A. Lynch
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
CBD and the 5-HT1A receptor: A medicinal and pharmacological review
Claire Alexander, Jiyoon Jeon, Kyle Nickerson, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116742-116742
Closed Access
Prolonged incubation with Δ9-tetrahydrocannabinol but not with cannabidiol induces synaptic alterations and mitochondrial impairment in immature and mature rat organotypic hippocampal slices
Costanza Mazzantini, Lorenzo Curti, Daniele Lana, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117797-117797
Closed Access
Psychedelics in neuroinflammation: Mechanisms and therapeutic potential
Júnia L. de Deus, Juliana Marino Maia, Renato Nery Soriano, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111278-111278
Closed Access
The role of cannabinoid-mediated signaling pathways and mechanisms in brain disorders
Shunfeng Liu, Zegang Ma
Cellular Signalling (2025), pp. 111653-111653
Closed Access
Dual action of sphingosine 1-phosphate pathway in in vitro models of global cerebral ischemia
Costanza Mazzantini, Martina Venturini, Daniele Lana, et al.
Neurobiology of Disease (2025) Vol. 208, pp. 106865-106865
Open Access
Cannabidiol Protects Against Neurotoxic Reactive Astrocytes‐Induced Neuronal Death in Mouse Model of Epilepsy
H. Ye, Yuhui Wan, Xin Wang, et al.
Journal of Neurochemistry (2025) Vol. 169, Iss. 3
Closed Access
A predictive machine learning model for cannabinoid effect based on image detection of reactive oxygen species in microglia
Patricia Sinclair, William Jeffries, Nadege Lebert, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0320219-e0320219
Open Access
Cannabidiol reverses myeloperoxidase hyperactivity in the prefrontal cortex and striatum, and reduces protein carbonyls in the hippocampus in a ketamine-induced schizophrenia rat model
Sofia de Almeida Queiroz, Linério Ribeiro de Novais Júnior, ANITA PACHECO, et al.
Schizophrenia Research (2025) Vol. 278, pp. 82-95
Closed Access
Herkinorin ameliorates neuronal damage in a pentylenetetrazol-induced epilepsy rat model through altering microglial and astrocytic activation by inhibiting PARP1 and NF-κB
Yun Liu, Wenmei Zhao, Xia Lv, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114588-114588
Closed Access
Anti-Inflammatory Properties of Cannabidiol and Beta-Caryophyllene Alone or Combined in an In Vitro Inflammation Model
Costanza Mazzantini, Zahraa El Bourji, Carmen Parisio, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 467-467
Open Access | Times Cited: 4
Comparative Investigation of Antimicrobial and Antioxidant Effects of the Extracts from the Inflorescences and Leaves of the Cannabis sativa L. cv. strawberry
Laura Serventi, Giancarlo Angeles Flores, Gaia Cusumano, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 219-219
Open Access | Times Cited: 10
Glial polarization in neurological diseases: Molecular mechanisms and therapeutic opportunities
Yuqing Liu, Lei Wu, Weijun Peng, et al.
Ageing Research Reviews (2024) Vol. 104, pp. 102638-102638
Closed Access | Times Cited: 3
Phenomic Microglia Diversity as a Druggable Target in the Hippocampus in Neurodegenerative Diseases
Daniele Lana, Giada Magni, Elisa Landucci, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13668-13668
Open Access | Times Cited: 7
The two synthetic cannabinoid compounds 4′‐F‐CBD and HU‐910 efficiently restrain inflammatory responses of brain microglia and astrocytes
Maurício dos Santos Pereira, Bruna M. Santos, Rocio Giménez, et al.
Glia (2023) Vol. 72, Iss. 3, pp. 529-545
Open Access | Times Cited: 7
Cannabidiol Anticonvulsant Effects Against Lithium-Pilocarpine-Induced Status Epilepticus in Male Rats Are Mediated by Neuroinflammation Modulation and Cannabinoids 1 (CB1), But Not CB2 and GABAA Receptors
Mahla Masoumi, Mohammad Amin Manavi, Razieh Mohammad Jafari, et al.
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 3, pp. 797-808
Closed Access | Times Cited: 6
Virtual Screening-Accelerated Discovery of a Phosphodiesterase 9 Inhibitor with Neuroprotective Effects in the Kainate Toxicity In Vitro Model
Elisa Landucci, Giovanni Ribaudo, Margrate Anyanwu, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 20, pp. 3826-3838
Open Access | Times Cited: 5
Cannabidiol protects against neurotoxic reactive astrocytes-induced neuronal death in mouse models of epilepsy
Haojie Ye, Yuhui Wan, Xin Wang, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Neuroprotective effects of pink lotus oil in kainic acid-induced epilepsy
Ratchaniporn Kongsui, Teera Chanmanee, Tichanon Promsrisuk, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e38070-e38070
Open Access | Times Cited: 1
Evaluation of the efficacy of a full-spectrum medicinal cannabis plant extract with less than 0.3% Delta9-tetrahydrocannabinol in in vitro models of inflammation and excitotoxicity
Emily Ross-Munro, Esra Isikgel, Bobbi Fleiss
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Recent advances in neuroinflammation prevention and therapy: the role of natural products and underlying mechanisms based on molecular targets
Meimei Zhao, Jun‐Yu Duan, Yue Shen, et al.
British Journal of Pharmacology (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top